United States was Aptargroup’s largest region in fiscal 2025, bringing in $1.07B of $3.78B (28%).
| Geography | FY 2009 | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $972.92M | $949.25M | $1.04B | $1.07B | |||||||||||
| Salesrevenuenet | — | — | — | — | |||||||||||
| Revenue, Net | — | — | — | — | |||||||||||
| France | $487.65M | $541.33M | $499.80M | $513.28M | |||||||||||
| Other Foreign Countries | $555.30M | $586.45M | $619.55M | $648.79M | |||||||||||
| Germany | $163.28M | $160.81M | $169.89M | $163.91M | |||||||||||
| Other Europe | $665.54M | $727.66M | $748.30M | $788.07M | |||||||||||
| Spain | $149.99M | $175.10M | $171.78M | $195.41M | |||||||||||
| Italy | $149.73M | $200.82M | $180.10M | $201.90M | |||||||||||
| China | $177.86M | $146.03M | $155.50M | $194.41M | |||||||||||
| Total | $3.32B | $3.49B | $3.58B | $3.78B |
Aptargroup brought in $3.78B from its eight regions in fiscal 2025, the year ended December 31, 2025. That was up 5.4% from $3.58B in fiscal 2024. United States was the largest at $1.07B (28.4%), ahead of Other Europe at $788.07M (20.9%) and Other Foreign Countries at $648.79M (17.2%). The other five regions brought in $1.27B combined.
Compared with fiscal 2024, China grew fastest, up 25.0% to $194.41M, while Germany fell the most, down 3.5% to $163.91M. From fiscal 2022 to 2025, combined revenue from these regions grew from $3.32B to $3.78B, a compound annual growth rate of 4.4%. United States' share of the total fell from 29.3% to 28.4%.
Pharma was Aptargroup’s largest segment in fiscal 2025, bringing in $1.74B of $3.81B (46%).
| Segment | FY 2009 | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aptar Beauty | $1.25B | — | — | — | ||||||||||||
| Pharma | — | $1.52B | $1.64B | $1.74B | ||||||||||||
| Beauty + Home | — | — | — | — | ||||||||||||
| Salesrevenuenet | — | — | — | — | ||||||||||||
| Revenue, Net | — | — | — | — | ||||||||||||
| Beauty | — | $1.30B | $1.25B | $1.34B | ||||||||||||
| Aptar Closures | $748.06M | — | — | — | ||||||||||||
| Closures | — | $706.85M | $721.56M | $736.94M | ||||||||||||
| Aptar Pharma | $1.37B | — | — | — | ||||||||||||
| Food + Beverage | — | — | — | — | ||||||||||||
| Food + Beverage | — | — | — | — | ||||||||||||
| Total | $3.37B | $3.53B | $3.62B | $3.81B |
Aptargroup brought in $3.81B from its three segments in fiscal 2025, the year ended December 31, 2025. That was up 5.4% from $3.62B in fiscal 2024. Pharma was the largest at $1.74B (45.6%), ahead of Beauty at $1.34B (35.1%) and Closures at $736.94M (19.3%).
Compared with fiscal 2024, Beauty grew fastest, up 6.8% to $1.34B. Every segment above 2% of revenue grew.
Aptargroup began breaking out Beauty in fiscal 2023 and Closures in fiscal 2023. Aptargroup stopped reporting Aptar Pharma ($1.37B in fiscal 2022), Aptar Beauty ($1.25B in fiscal 2022) and Aptar Closures ($748.06M in fiscal 2022) as separate segments.
Balances Without Adoption Of Asc 606 was Aptargroup’s largest revenue line in fiscal 2018, bringing in $1.42B of $1.43B (100%).
| Initial Application Period Cumulative Effect Transition | FY 2018 |
|---|---|
| Balances Without Adoption Of Asc 606 | $1.42B |
| Adjustment/Effect Of Change | $1.68M |
| Total | $1.43B |
Aptargroup brought in $1.43B from its two revenue lines in fiscal 2018, the year ended December 31, 2018. Balances Without Adoption Of Asc 606 was the largest at $1.42B (99.9%), ahead of Adjustment/Effect Of Change at $1.68M (0.1%).
Aptargroup (ATR) reports its revenue by geography, by segment and by initial application period cumulative effect transition. In fiscal 2025, United States was its largest region, bringing in $1.07B (28.4% of the total), followed by Other Europe at $788.07M (20.9%).
United States was Aptargroup's largest region in fiscal 2025, bringing in $1.07B, or 28.4% of the $3.78B total across its eight regions.
Pharma was Aptargroup's largest segment in fiscal 2025, bringing in $1.74B, or 45.6% of the $3.81B total across its three segments.
Balances Without Adoption Of Asc 606 was Aptargroup's largest revenue line in fiscal 2018, bringing in $1.42B, or 99.9% of the $1.43B total across its two revenue lines.
Among Aptargroup's regions that make up at least 2% of revenue, China grew fastest in fiscal 2025, up 25.0% from $155.50M to $194.41M.
Every figure comes from Aptargroup's annual financial filings, as reported. Each line keeps the name Aptargroup gives it, and years follow its fiscal calendar.
Aptargroup's revenue by geography goes back to fiscal 2009, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.